Metagenomic Markets. Global Market Analysis with Forecasts by Applications, Technologies, Product and User. With Executive and Consultant Guides. 2026 to 2030

List of Tables

Report Overview:

Unlimited growth potential? A Game Changer? It is not exaggeration. Metagenomic assays could change the way medical treatment is done. Learn all about it in this new research report.

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower costs is driving a new type of genetic testing. ItIs a whole new approach. Chronic infection? Find out the real culprits. Secrets of the microbiome and gut health? Metagenomics has the answers. In everything from human medical treatment to wastewater studies this new approach is creating startling answers. Already some minor medical miracles have been accomplished. This report looks at the technology, the applications, the users and the types of products that will be sold. The report includes detailed breakouts for 14 countries and 5 regions.

Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

1. Market Guides

1.1. Strategic Situation Analysis
1.2. Guide for Executives and Business Development Staff
1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

2.1. What is Metagenomics?
2.2. Market Definition
- 2.2.1. Revenue Market Size.
- 2.2.2. Clinical
- 2.2.3. Microbiome
- 2.2.4. Agricultural
- 2.2.5. Environmental & Other
2.3. Methodology
- 2.3.1. Methodology
- 2.3.2. Sources
- 2.3.3. Authors
2.4. Perspective: Healthcare Spending
- 2.4.1. Global Healthcare Spending
- 2.4.2. Spending on Healthcare and Pharmaceuticals
- 2.4.3. Spending on Diagnostics
- 2.4.4. Important Role of Insurance for Medical Services
2.5. Chromosomes, Genes and Epigenetics
- 2.5.1. Chromosomes
- 2.5.2. Genes
- 2.5.3. Epigenetics

3. Market Overview

3.1. Players in a Dynamic Market
- 3.1.1. Academic Research Lab
- 3.1.2. Diagnostic Test Developer
- 3.1.3. Instrumentation Supplier
- 3.1.4. Chemical/Reagent Supplier
- 3.1.5. Pathology Supplier
- 3.1.6. Independent Clinical Laboratory
- 3.1.7. Public National/regional Laboratory
- 3.1.8. Hospital Laboratory
- 3.1.9. Physicians Office Lab (POLS)
- 3.1.10. Audit Body
- 3.1.11. Certification Body
3.2. Metagenomics Applications
- 3.2.1. Clinical Metagenomics
- 3.2.2. Diagnostic Use
- 3.2.3. Syndromic Multiplex vs. Metagenomic Testing
- 3.2.4. Antimicrobial Resistance
- 3.2.5. Managing the Microbiome
- 3.2.6. Public Health Use
3.3. Clinical Industry Structure
- 3.3.1. Hospital's Testing Share
- 3.3.2. Economies of Scale
- 3.3.3. Hospital vs. Central Lab
- 3.3.4. Physician Office Lab's
- 3.3.5. Physician's and POCT

4. Market Trends

4.1. Factors Driving Growth
- 4.1.1. A New Approach to Diagnostics
- 4.1.2. The Aging Effect
- 4.1.3. The Known and the Unknown
- 4.1.4. A Research Bonanza
4.2. Factors Limiting Growth
- 4.2.1. Increased Competition Lowers Price
- 4.2.2. Lower Costs
- 4.2.3. Testing usage analysis curtailing growth
- 4.2.4. Wellness has a downside
4.3. Instrumentation, Automation and Diagnostic Trends
- 4.3.1. Traditional Automation and Centralization
- 4.3.2. The New Automation, Decentralization and Point of Care
- 4.3.3. Instruments Key to Market Share
- 4.3.4. Bioinformatics Plays a Role
- 4.3.5. PCR Takes Command
- 4.3.6. Next Generation Sequencing Fuels a Revolution
- 4.3.7. NGS Impact on Pricing
- 4.3.8. Whole Genome Sequencing, A Brave New World
- 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
- 4.3.10. Shifting Role of Diagnostics

5. Metagenomics Recent Developments

5.1. Recent Developments
- 5.1.1. Importance of This Section
- 5.1.2. How to Use This Section
5.2. iconPCR Used in Metagenomics Discovery
5.3. Mapmygenome acquires Canada's Microbiome Insights
5.4. Hamilton to Partner With Labor Berlin, Claret Bioscience
5.5. Complicated UTIs Using Rapid Metagenomics
5.6. Delve Bio Showing Delivers Greater Diagnostic Yield
5.7. Sewage metagenomics potentially allows surveillance
5.8. Rapid metagenomics to reduce AMR and sepsis
5.9. UK and U.S. Use Metagenomics for Biothreat Assessment
5.10. Phase Genomics Metagenomics Innovation Award
5.11. New Method for Human Gut Assessment
5.12. Metagenomic sequencing Used for Pneumonia Care
5.13. Sepsis Study Shows Metagenomic Clinical Value
5.14. Delve Bio to Develop Metagenomic Sequencing Dx
5.15. Metagenomics Could be a Game-changer
5.16. Model Predicts Millions of Metagenomic Proteins
5.17. Microbiome Analysis May Yield False Results
5.18. Gut microbiome at center of Parkinson's disease
5.19. MicroGenDx, Evvy Partner for Metagenomic Test
5.20. Diagnostic accuracy of metagenomic NGS
5.21. Metagenomics implicates the gut microbiome
5.22. Charities Award $2M for Metagenomic Pathogen Research
5.23. Cost-effective metagenomic HiFi sequencing
5.24. Microbiome Links Uncovered
5.25. Metagenomi Named an Endpoints 11 Winner
5.26. Biotia Raises $8M in Series A Financing

6. Profiles of Key Companies

6.1. BaseClear
6.2. BGI Genomics Co. Ltd
6.3. Biome Makers
6.4. bioMerieux Diagnostics
6.5. Bio-Rad Laboratories, Inc
6.6. Bioscientia Institut fur Medizinische Diagnostik GmbH
6.7. Cantata Bio
6.8. CosmosID
6.9. Day Zero Diagnostics.
6.10. Element Biosciences
6.11. Fusion Genomics.
6.12. Genolution
6.13. Helix
6.14. Illumina
6.15. Institute for Metagenomics
6.16. Karius
6.17. Metabiomics Corp
6.18. Metagenomi
6.19. MetaSUB International Consortium
6.20. Microbiome Insights
6.21. MicroGenDx
6.22. Norgen Biotek Corp.
6.23. Noscendo
6.24. Novogene
6.25. One Codex
6.26. OraSure Technologies
6.27. Oxford Nanopore Technologies
6.28. Pacific Biosciences
6.29. PathoQuest S.A.
6.30. Promega
6.31. Qiagen
6.32. Revvity
6.33. Second Genome
6.34. Siemens Healthineers
6.35. Superfluid Dx
6.36. Sysmex
6.37. Takara Bio
6.38. Zymo Research Corp

7. Global Market Size

7.1. Global Market by Country
- 7.1.1. Table - Global Market by Country
- 7.1.2. Chart - Country Market Shares
7.2. Global Market by Application
- 7.2.1. Table - Global Market by Application
- 7.2.2. Chart - Application Share by Year
- 7.2.3. Chart - Application Segment Growth Rates
- 7.2.4. Chart - Application Segment Share Shifts
- 7.2.5. Chart - Application Segment Share Base Year
- 7.2.6. Chart - Application Segment Share Final Year
7.3. Global Market by Technology
- 7.3.1. Table - Global Market by Technology
- 7.3.2. Chart - Technology Share by Year
- 7.3.3. Chart - Technology Segment Growth Rates
- 7.3.4. Chart - Technology Segment Share Shifts
- 7.3.5. Chart - Technology Segment Share Base Year
- 7.3.6. Chart - Technology Segment Share Final Year
7.4. Global Market by Product
- 7.4.1. Table - Global Market by Product
- 7.4.2. Chart - Product Share by Year
- 7.4.3. Chart - Product Segment Growth Rates
- 7.4.4. Chart - Product Segment Share Shifts
- 7.4.5. Chart - Product Segment Share Base Year
- 7.4.6. Chart - Product Segment Share Final Year
7.5. Global Market by User
- 7.5.1. Table - Global Market by User
- 7.5.2. Chart - User Share by Year
- 7.5.3. Chart - User Segment Growth Rates
- 7.5.4. Chart - User Segment Share Shifts
- 7.5.5. Chart - User Segment Share Base Year
- 7.5.6. Chart - User Segment Share Final Year

8. Market Sizes by Application

8.1. Clinical Market
- 8.1.1. Table Clinical - by Country
- 8.1.2. Chart - Clinical Growth
8.2. Microbiome Market
- 8.2.1. Table Microbiome - by Country
- 8.2.2. Chart - Microbiome Growth
8.3. Agriculture Market
- 8.3.1. Table Agriculture - by Country
- 8.3.2. Chart - Agriculture Growth
8.4. Industrial & Other Market
- 8.4.1. Table Industrial & Other - by Country
- 8.4.2. Chart - Industrial & Other Growth

9. Market Sizes by Technology

9.1. 16srRNA Market
- 9.1.1. Table 16srRNA - by Country
- 9.1.2. Chart - 16srRNA Growth
9.2. Shotgun Market
- 9.2.1. Table Shotgun - by Country
- 9.2.2. Chart - Shotgun Growth
9.3. WGS Market
- 9.3.1. Table WGS - by Country
- 9.3.2. WGS - Growth
9.4. Other Technology Market
- 9.4.1. Table Other Technology - by Country
- 9.4.2. Chart - Other Technology Growth

10. Market Sizes by Product

10.1. Instruments Market
- 10.1.1. Table Instruments - by Country
- 10.1.2. Chart - Instrument Growth
10.2. Reagents and Kits Market
- 10.2.1. Table Reagents and Kits - by Country
- 10.2.2. Chart - Reagents and Kits Growth
10.3. Software Market
- 10.3.1. Table Software - by Country
- 10.3.2. Software Growth
10.4. Services Market
- 10.4.1. Table Services - by Country
- 10.4.2. Chart - Services Growth

11. Market Sizes by User

11.1. Academic Market
- 11.1.1. Table Academic - by Country
- 11.1.2. Chart - Academic Growth
11.2. Clinical Market
- 11.2.1. Table Clinical - by Country
- 11.2.2. Chart - Clinical Growth
11.3. Pharmaceutical Market
- 11.3.1. Table Pharmaceutical - by Country
- 11.3.2. Pharmaceutical - Predictive Growth
11.4. Other User Market
- 11.4.1. Table Other User - by Country
- 11.4.2. Chart - Other User Growth

12. Appendices

12.1. United States Medicare System: Laboratory Fees Schedule
12.2. The Most Used IVD Assays
12.3. The Highest Grossing Assays

Table of Tables

Table 1: The Base Pairs
Table 2: Market Players by Type
Table 3: The Different Applications of Metagenomic Testing
Table 4: Factors Driving Growth
Table 5: Four Factors Limiting Growth
Table 6: Seven Key Diagnostic Laboratory Technology Trends
Table 7: Global Market by Country
Table 8: Global Market by Application
Table 9: Global Market by Technology
Table 10: Global Market by Product
Table 11: Global Market by User
Table 12: Clinical Segment by Country
Table 13: Microbiome Segment by Country
Table 14: Agriculture Segment by Country
Table 15: Industrial & Other Segment by Country
Table 16 16srRNA Segment by Country
Table 17: Shotgun Segment by Country
Table 18: WGS Segment by Country
Table 19: Other Technology Segment by Country
Table 20: Instruments Segment by Country
Table 21: Reagents and Kits Segment by Country
Table 22: Software Segment by Country
Table 23: Services Segment by Country
Table 24: Academic Segment by Country
Table 25: Clinical Segment by Country
Table 26: Pharmaceutical Segment by Country
Table 27: Other User Segment by Country
Table 28: Clinical Lab Fee Schedule
Table 29: The Most Common Assays
Table 30: Largest Revenue Assays

Table of Figures

Figure 1: Global Healthcare Spending
Figure 2: DNA Strands and Chromosomes
Figure 3: Karyogram of Human Chromosomes
Figure 4: Size of Various Genomes
Figure 5: The Road to Diagnostics
Figure 6: The New Diagnostics
Figure 7: The Changing Age of the World Population
Figure 8: Health Care Consumption by Age
Figure 9: Cancer Incidence - Age at Diagnosis
Figure 10: Centralized vs. Decentralized Laboratory Service
Figure 11: A Highly Multiplexed Syndromic Testing Unit
Figure 12: The Real Cost to Sequence the Human Genome
Figure 13: The Codevelopment Process
Figure 14: Comparing MDx Diagnostic and Traditional Testing
Figure 15: Country Market Shares
Figure 16: Application Share by Year
Figure 17: Application Segment Growth Rates
Figure 18: Segment Share Shifts
Figure 19: Application Segment Share Base Year
Figure 20: Application Segment Share Final Year
Figure 21: Technology Share by Year
Figure 22: Technology Segment Growth Rates
Figure 23: Technology Segment Share Shifts
Figure 24: Technology Segment Share Base Year
Figure 25: Technology Segment Share Final Year
Figure 26: Product Share by Year
Figure 27: Product Segment Growth Rates
Figure 28: Product Segment Share Shifts
Figure 29: Product Segment Share Base Year
Figure 30: Product Segment Share Final Year
Figure 31: User Share by Year
Figure 32: User Segment Growth Rates
Figure 33: User Segment Share Shifts
Figure 34: User Segment Share Base Year
Figure 35: User Segment Share Final Year
Figure 36: Clinical vs. Total Market Growth
Figure 37: Microbiome vs. Total Market Growth
Figure 38: Agriculture vs. Total Market Growth
Figure 39: Industrial & Other vs. Total Market Growth
Figure 40 16srRNA vs. Total Market Growth
Figure 41: Shotgun vs. Total Market Growth
Figure 42: WGS vs. Total Market Growth
Figure 43: Other Technology vs. Total Market Growth
Figure 44: Instrument vs. Total Market Growth
Figure 45: Reagents and Kits vs. Total Market Growth
Figure 46: Software vs. Total Market Growth
Figure 47: Services vs. Total Market Growth
Figure 48: Academic vs. Total Market Growth
Figure 49: Clinical vs. Total Market Growth
Figure 50: Pharmaceutical vs. Total Market Growth
Figure 51: Other User Growth